Chinook Therapeutics Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
| Owner Type | Number of Shares | Ownership Percentage |
|---|---|---|
| Private Companies | 5,029 | 0.007% |
| Individual Insiders | 1,134,207 | 1.58% |
| General Public | 6,197,576 | 8.63% |
| VC/PE Firms | 9,507,447 | 13.2% |
| Institutions | 54,960,718 | 76.5% |
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 14.2%.
Top Shareholders
| Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
|---|---|---|---|---|---|---|
| 5,161,888 | US$208.5m | 0% | 39.26% | |||
| 4,345,559 | US$175.5m | 0% | 10.89% | |||
| 3,942,539 | US$159.2m | -0.31% | no data | |||
| 3,035,207 | US$122.6m | 0% | 29.86% | |||
| 3,000,000 | US$121.2m | 0% | 4.29% | |||
| 2,847,835 | US$115.0m | 1.98% | no data | |||
| 2,688,048 | US$108.6m | 1.09% | 0.01% | |||
| 2,551,703 | US$103.1m | 0% | 16.05% | |||
| 2,029,300 | US$82.0m | 0% | 1.24% | |||
| 1,704,000 | US$68.8m | 108% | 0.14% | |||
| 1,568,797 | US$63.4m | 8.58% | 2.75% | |||
| 1,455,202 | US$58.8m | -42.6% | 0.32% | |||
| 1,439,564 | US$58.1m | 290% | 1.02% | |||
| 1,336,934 | US$54.0m | 4.08% | 0.01% | |||
| 1,302,229 | US$52.6m | 0% | 0.02% | |||
| 1,252,388 | US$50.6m | 41% | 0.13% | |||
| 1,174,756 | US$47.4m | 0.74% | 0.04% | |||
| 1,002,348 | US$40.5m | 24.3% | 2.78% | |||
| 976,021 | US$39.4m | 19.3% | 16.68% | |||
| 972,191 | US$39.3m | 51.3% | 3.03% | |||
| 948,551 | US$38.3m | 3.75% | no data | |||
| 872,151 | US$35.2m | 0% | 3.65% | |||
| 829,750 | US$33.5m | 0% | 1.42% | |||
| 826,155 | US$33.4m | -10.8% | 0.1% | |||
| 755,336 | US$30.5m | -2.25% | 0.27% |